Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Revista
Intervalo de año de publicación
1.
AIDS ; 27 Suppl 2: S215-24, 2013 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24361631

RESUMEN

Treatment 2.0 is an initiative launched by UNAIDS and WHO in 2011 to catalyze the next phase of treatment scale-up for HIV. The initiative defines strategic activities in 5 key areas, drugs, diagnostics, commodity costs, service delivery and community engagement in an effort to simplify treatment, expand access and maximize program efficiency. For adults, many of these activities have already been turned into treatment policies. The recent WHO recommendation to use a universal first line regimen regardless of gender, pregnancy and TB status is a treatment simplification very much in line with Treatment 2.0. But despite that fact that Treatment 2.0 encompasses all people living with HIV, we have not seen the same evolution in policy development for children. In this paper we discuss how Treatment 2.0 principles can be adapted for the pediatric population. There are several intrinsic challenges. The need for distinct treatment regimens in children of different ages makes it hard to define a one size fits all approach. In addition, the fact that many providers are reluctant to treat children without the advice of specialists can hamper decentralization of service delivery. But at the same time, there are opportunities that can be availed now and in the future to scale up pediatric treatment along the lines of Treatment 2.0. We examine each of the five pillars of Treatment 2.0 from a pediatric perspective and present eight specific action points that would result in simplification of pediatric treatment and scale up of HIV services for children.


Asunto(s)
Fármacos Anti-VIH/uso terapéutico , Atención Integral de Salud , Infecciones por VIH , Transmisión Vertical de Enfermedad Infecciosa/prevención & control , Pediatría/normas , Adulto , Fármacos Anti-VIH/economía , Niño , Análisis Costo-Beneficio , Prestación Integrada de Atención de Salud , Industria Farmacéutica/economía , Femenino , Salud Global , Infecciones por VIH/diagnóstico , Infecciones por VIH/tratamiento farmacológico , Infecciones por VIH/economía , Infecciones por VIH/transmisión , Necesidades y Demandas de Servicios de Salud , Humanos , Lactante , Recién Nacido , Pediatría/educación , Embarazo , Desarrollo de Programa , Organización Mundial de la Salud
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA